LLR Partners Engages Robert Feeney as Senior Operating Advisor to Support Investments in Pharma Patient Services

April 28, 2023

LLR Partners has engaged Robert Feeney, an experienced healthcare services leader, as a Senior Operating Advisor. In this role, Feeney will leverage his insights and industry experience to help LLR identify, evaluate and manage new investment opportunities in pharmaceutical patient services.

“Rob has spent 20 years pioneering technologies and business models that brought healthcare constituents together to improve patient care,” said Zack Sigal, Partner at LLR. “With the rapid growth of highly specialized pharmaceutical therapies, we believe our overburdened healthcare system needs to find new ways to help patients and providers navigate a complicated network of options. We are excited to collaborate with Rob and the companies who are advancing a patient-centric support model that empowers patients and physicians at the point of care.”

Read Rob’s perspective on some of the biggest changes and pharma patient services trends impacting the patient journey and their impact on future growth for this sector in LLR GrowthBits – Pharma Tech: The Next Wave Will Focus on Patients at the Point of Care.

“As a Senior Operating Advisor at LLR, I can apply my experience in patient engagement, specialty pharmacy and supply chain services to support the firm’s continued investments in pharmaceutical patient services, a space that is ripe for the next wave of innovation,” said Feeney. “Together, we see tremendous growth opportunities for a new generation of technology-enabled programs that wrap around the patient and provider relationship, delivering vital patient support services in real-time.”

Rob Feeney is a serial entrepreneur who successfully founded, commercialized and exited multiple technology-enabled healthcare services businesses across the consumer, payor, provider and pharma services sectors. He built medical device company, ISL Inc., from concept through IPO; was part of the management team who built and sold Pyxis Corporation to Cardinal Health; and most recently founded and grew Medvantx into the pharma industry’s largest vertically-integrated patient access platform.

LLR’s investment focus in Pharmaceutical Patient Services includes:

  • Hub Services: Single outsourced providers of patient services, aggregating data and insights across stakeholders
  • Coverage: Solutions that help drive increased automation to benefits verification and prior authorization for the medical and pharmacy benefit
  • Financial Assistance: Solutions that improve access to financial assistance

LLR’s long history of investing in and helping to grow tech-enabled biopharmaceutical and patient service companies includes Medmark, a provider of specialty drugs, supplies and services; SDI, a provider of data products and analytics services to pharma manufacturers; Phreesia, a patient intake and payments platform Suvoda, a provider of clinical solutions for clinical trials; and Real-Time, a clinical research site software company.

About LLR Partners

LLR Partners is a private equity firm investing in technology and healthcare businesses. We collaborate with our portfolio companies to identify and execute on key growth initiatives and help create long-term value. Founded in 1999 and with more than $5 billion raised across six funds, LLR is a flexible provider of equity capital for growth, recapitalizations and buyouts. Senior Operating Advisors are engaged by LLR as consultants.